Clinical Trial Update: Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot study examining the effects of switching to aripiprazole on health and smoking parameters in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Veterans Medical Research Foundation | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED